Source: Breast cancer research and treatment. Unidade: FM
Subjects: NEOPLASIAS MAMÁRIAS, ANTINEOPLÁSICOS, TERAPIA DE REPOSIÇÃO DE ESTRÓGENOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PAVANELLI, Ana Carolina et al. Comprehensive immunohistochemical analysis of RET, BCAR1, and BCAR3 expression in patients with Luminal A and B breast cancer subtypes. Breast cancer research and treatment, v. 192, n. 1, p. 43-52, 2022Tradução . . Disponível em: https://doi.org/10.1007/s10549-021-06452-9. Acesso em: 01 nov. 2024.APA
Pavanelli, A. C., Mangone, F. R., Yoganathan, P., Bessa, S. A., Nonogaki, S., Osorio, C. A. B. de T., et al. (2022). Comprehensive immunohistochemical analysis of RET, BCAR1, and BCAR3 expression in patients with Luminal A and B breast cancer subtypes. Breast cancer research and treatment, 192( 1), 43-52. doi:10.1007/s10549-021-06452-9NLM
Pavanelli AC, Mangone FR, Yoganathan P, Bessa SA, Nonogaki S, Osorio CAB de T, Andrade VP de, Soares IC, Mello ES de, Mulligan LM, Nagai MA. Comprehensive immunohistochemical analysis of RET, BCAR1, and BCAR3 expression in patients with Luminal A and B breast cancer subtypes [Internet]. Breast cancer research and treatment. 2022 ; 192( 1): 43-52.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1007/s10549-021-06452-9Vancouver
Pavanelli AC, Mangone FR, Yoganathan P, Bessa SA, Nonogaki S, Osorio CAB de T, Andrade VP de, Soares IC, Mello ES de, Mulligan LM, Nagai MA. Comprehensive immunohistochemical analysis of RET, BCAR1, and BCAR3 expression in patients with Luminal A and B breast cancer subtypes [Internet]. Breast cancer research and treatment. 2022 ; 192( 1): 43-52.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1007/s10549-021-06452-9